Angela Cioffi

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

Inflammation, Allergy, Lung Inflammation +11

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial

Axel Le Cesne, Isabelle Ray‐Coquard, Binh Bui et al. · The Lancet Oncology · 2010 · 293 citations

Gastrointestinal Oncology, Medicine, Gastroenterology +8

Advanced chondrosarcomas: role of chemotherapy and survival

Antoîne Italiano, Olivier Mir, Angela Cioffi et al. · Annals of Oncology · 2013 · 242 citations · Full text

Surgical Oncology, Medicine, Surgical Pathology +7

Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes

Patrick Schöffski, Isabelle Laure Ray-Coquard, Angela Cioffi et al. · The Lancet Oncology · 2011 · 236 citations

Soft-tissue Sarcoma, Pathology, Phase 2 +2

Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)

Patricia Pautier, Anne Floquet, Nicolas Penel et al. · The Oncologist · 2012 · 203 citations · Full text